Articles tagged with 'CRM' | BIOTRONIK

BIOTRONIK - Archive (CRM)

2020
September
17,
2020
| 19:30 PM Europe/Amsterdam
Almost 30 years after the US FDA rescinded a ban on women of “childbearing potential” from participating in clinical studies, women remain underrepresented in many key areas for medical trials—including cardiovascular medicine. This is despite guidan...
Read more
2019
July
22,
2019
| 13:35 PM Europe/Amsterdam
BIOTRONIK today announced the publication of the SENSE Trial results in the Journal of Cardiac Electrophysiology, proving BIOTRONIK’s DX system is equivalent to dual-chamber implantable cardioverter defibrillators (ICDs) in detecting atrial high-rate...
Read more
July
08,
2019
| 13:48 PM Europe/Amsterdam
BIOTRONIK today announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to document suspected arrhythmia or unexplained syncope with increased clarity, enabling fast diagnosis and appropriate treatme...
Read more
May
06,
2019
| 13:53 PM Europe/Amsterdam
BIOTRONIK today announced initial enrollment into the BIO-LIBRA study, a first-of-its kind, large-scale prospective study to analyze sex-specific outcomes in patients with non-ischemic cardiomyopathy (NICM) treated with cardiac defibrillator device t...
Read more
April
29,
2019
| 14:02 PM Europe/Amsterdam
BIOTRONIK today announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Leading electrophysiologists throughout the United States are now treating patients with the new implantable cardioverter defi...
Read more
March
14,
2019
| 14:11 PM Europe/Amsterdam
BIOTRONIK today announced FDA approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for treatment of patients with cardiac arrhythmias. The six new tachycardia solutions include Rivacor VR-T, Rivacor DR-T, R...
Read more
2018
August
27,
2018
| 19:39 PM Europe/Amsterdam
BIOTRONIK today announced that the company is now the exclusive US distributor for InfoBionic’s MoMe Kardia external cardiac diagnostic monitor. The device benefits patients suspected of experiencing cardiac arrhythmias. Patients experiencing card...
Read more
April
03,
2018
| 19:46 PM Europe/Amsterdam
BIOTRONIK US and Aziyo today announced a strategic agreement allowing BIOTRONIK to distribute Aziyo’s CanGaroo® extracellular matrix (ECM) cardiovascular implantable electronic device (CIED) envelopes in the United States. BioEnvelope will be availab...
Read more